Spencer Pharmaceutical Inc. (SPPH)

Spencer Pharmaceutical Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2010	FY 2009	FY 2008
Period Ending	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008
Revenue	-	-	0.44
Gross Profit	-	-	0.44
Selling, General & Admin	0.94	-	-
Operating Expenses	0.94	-	-
Operating Income	-0.94	-	0.44
Pretax Income	-0.94	-	0.44
Net Income	-0.94	-	0.44
Net Income to Common	-0.94	-	0.44
Shares Outstanding (Basic)	271	203	48
Shares Outstanding (Diluted)	271	203	48
Shares Change (YoY)	33.68%	320.29%	-
EPS (Basic)	-0.00	-	0.01
EPS (Diluted)	-0.00	-	0.01
Gross Margin	-	-	100.00%
Operating Margin	-	-	100.00%
Profit Margin	-	-	100.00%
EBIT	-0.94	-	0.44
EBIT Margin	-	-	100.00%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.